Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Revenue

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,477 Cr₹1,559 Cr₹1,191 Cr₹951 Cr₹937 Cr

What is the latest Revenue of NEULAND LABORATORIES ?

The latest Revenue ratio of NEULAND LABORATORIES is ₹1,477 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,477 Cr
Mar2024₹1,559 Cr
Mar2023₹1,191 Cr
Mar2022₹951 Cr
Mar2021₹937 Cr

How is Revenue of NEULAND LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹1,477 Cr
-5.24
Mar2024 ₹1,559 Cr
30.84
Mar2023 ₹1,191 Cr
25.25
Mar2022 ₹951 Cr
1.51
Mar2021 ₹937 Cr -

Compare Revenue of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹18,232.3 Cr -2.5% 16.4% 70.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2.5%

16.4%

70.8%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses